Elevated levels of sialylation in tumor cells can enhance the presentation of sialylated ligands such as Mucin proteins (e.g., MUC1), CD24, and sialylated IgG on the cell surface, further facilitating their interactions with specific receptors known as Siglecs38-41. Here, CD24 is linked to neoplasm.